Clinical Trial Update: HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis [Phase 2]

View source ↗

Summary

Phase 2 HOPE Consortium trial in end-stage renal disease evaluated strategies to reduce pain and opioid use in hemodialysis patients. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Opioid Use Disorder
• Pain

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: End Stage Renal Disease, Chronic Pain | Phase 2 | Status: COMPLETED | Results posted: 2025-01-13